Recombinant antibodies possessing novel effector functions View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1984-12

AUTHORS

Michael S. Neuberger, Gareth T. Williams, Robert O. Fox

ABSTRACT

The introduction into lymphocytes of immunoglobulin-gene DNA that has been manipulated in vitro allows the production of novel antibodies. In this way, cell lines have been established that secrete hapten-specific antibodies in which the Fc portion has been replaced either with an active enzyme moiety or with polypeptide displaying c-myc antigenic determinants. More... »

PAGES

604

Journal

TITLE

Nature

ISSUE

5995

VOLUME

312

Related Patents

  • Mutant Receptors And Their Use In A Nuclear Receptor-Based Inducible Gene Expression System
  • Apo-2 Receptor Polypeptides
  • Whitefly Ecdysone Receptor Nucleic Acids, Polypeptides, And Uses Thereof
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Hepatitis C Virus Codon Optimized Non-Structural Ns3/4a Fusion Gene
  • Compositions, Reagents And Kits For And Methods Of Diagnosing, Monitoring And Treating Hormonal Imbalance
  • Phosphospecific Chemokine Receptor Antibodies
  • Recombinant Tumor Specific Antibody And Use Thereof
  • Treatment Of Autoimmune Diseases
  • Methods Of Modulating Apoptosis By Administration Of Relaxin Agonists Or Antagonists
  • Human Dectin Proteins And Polynucleotides Encoding The Same
  • Human Gaba Transporter Protein And Polynucleotides Encoding The Same
  • Antibodies That Bind To Α2-Antiplasmin Crosslinked To Fibrin Which Do Not Inhibit Plasma Α2-Antiplasmin
  • Human Kinase And Polynucleotides Encoding The Same
  • Human Kinases And Polynucleotides Encoding The Same
  • Human Kinase Proteins And Polynucleotides Encoding The Same
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Human Kinase Proteins And Polynucleotides Encoding The Same
  • Adheson Variants
  • Methods Of Inhibiting Osteoclastogenesis
  • Antibody Conjugates Reactive With Human Carcinomas
  • Chromosome 18 Marker
  • Modular Assembly Of Antibody Genes, Antibodies Prepared Thereby And Use
  • Modular Assembly Of Antibody Genes, Antibodies Prepared Thereby And Use
  • Methods Of Determining Protein Activity Levels Using Gene Expression Profiles
  • Methods For Removing Artifact From Biological Profiles
  • Polynucleotides Encoding Human Ion-Exchanger Proteins
  • Human Kinases And Polynucleotides Encoding The Same, And Uses Thereof
  • Anti-Psca Antibodies
  • Methods For Producing Members Of Specific Binding Pairs
  • Chimeric Antibody With Specificity To Human B Cell Surface Antigen
  • Human Kinase And Polynucleotides Encoding The Same
  • Hybrid Immunoglobulin-Thrombolytic Enzyme Molecules Which Specifically Bind A Thrombus, And Methods Of Their Production And Use
  • Random Peptide Library
  • Pyk2 Related Polynucleotide Products
  • Antibodies Reactive With Human Carcinomas
  • Modified Plasminogen Activator Inhibitor Type-1 Molecule And Methods Based Thereon
  • B. Anthracis Prevention And Treatment: Mutant B. Anthracis Lacking Luxs Activity And Furanone Inhibition Of Growth, Ai-2 Quorum Sensing, And Toxin Production
  • Neutralizing Antibodies And Fragments Thereof Directed Against Platelet Factor-4 Variant 1 (Pf4v1)
  • Nucleic Acid Molecules Encoding Transmembrane Serine Proteases, The Encoded Proteins And Methods Based Thereon
  • Enhancing The Circulating Half-Life Of Antibody-Based Fusion Proteins
  • Human Anti-Opgl Neutralizing Antibodies As Selective Opgl Pathway Inhibitors
  • Arl-1 Specific Antibodies
  • Compositions And Methods For The Therapy And Diagnosis Of Influenza
  • Methods For Treating Progressive Multiple Sclerosis
  • Constructs Targeting Afp Peptide/Mhc Complexes And Uses Thereof
  • Organic Compounds
  • Interleukin-13 Binding Proteins
  • Interleukin-13 Binding Proteins
  • Methods For Cancer Management Targeting Co-029
  • Compositions And Methods For The Therapy And Diagnosis Of Influenza
  • Mutant Receptors And Their Use In A Nuclear Receptor-Based Inducible Gene Expression System
  • Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
  • Compositions And Methods For The Therapy And Diagnosis Of Influenza
  • Anti-Pmel17 Antibodies And Immunoconjugates
  • Human Rhinovirus (Hrv) Antibodies
  • Ephb3-Specific Antibody And Uses Thereof
  • Inhibitors Of The Epidermal Growth Factor Receptor-Heat Shock Protein 90 Binding Interaction
  • Modular Assembly Of Antibody Genes, Antibodies Prepared Thereby And Use
  • Anti-Pmel17 Antibodies And Immunoconjugates
  • Knockout Animals Manifesting Hyperlipidemia
  • Compositions And Methods For Treating Cancer By Modulating Her-2 And Egf Receptors
  • Antibodies That Bind To Α2-Antiplasmin Crosslinked To Fibrin Which Do Not Inhibit Plasma Α2-Antiplasmin
  • Thrombopoietic Compounds
  • Bcr-Abl Truncation Mutations
  • Glycosylated Specificity Exchangers
  • Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
  • Tgf-Beta-Specific Antibodies And Methods Of Use Thereof For Treatment
  • Composition And Method For The Diagnosis And Treatment Of Diseases Associated With Neurite Degeneration
  • Combination Of Fcγriib-Specific Antibodies And Cd20-Specific Antibodies And Methods Of Use Thereof
  • Bioavailable Diacylhydrazine Ligands For Modulating The Expression Of Exogenous Genes Via An Ecdysone Receptor Complex
  • Hepatitis C Virus Non-Structural Ns3/4a Fusion Gene
  • Il-1 Binding Proteins
  • Chimeric Antibody With Specificity To Human B Cell Surface Antigen
  • Mutant Br96 Antibodies Reactive With Human Carcinomas
  • Human Anti-Opgl Neutralizing Antibodies As Selective Opgl Pathway Inhibitors
  • Il-1 Binding Proteins
  • Hepatitis C Virus Codon Optimized Non-Structural Ns3/4a Fusion Gene
  • Glycosylated Specificity Exchangers
  • Compositions And Methods For Treating Cancer By Modulating Her-2 And Egf Receptors
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Chimeric Retinoid X Receptors And Their Use In A Novel Ecdysone Receptor-Based Inducible Gene Expression System
  • Methods For Inhibiting The Growth Of Cancer Cells Expressing Psca
  • Aβ Conformer Selective Anti-Aβ Globulomer Monoclonal Antibodies
  • Ecdysone Receptor/Invertebrate Retinoid X Receptor-Based Inducible Gene Expression System
  • Amyloid-Beta Binding Proteins
  • Compounds And Method Of Identifying, Synthesizing, Optimizing And Profiling Protein Modulators
  • Anti-B7-H4 Antibodies And Immunoconjugates
  • Method For Making Humanized Antibodies
  • Human Calcium Dependent Proteases, Polynucleotides Encoding The Same, And Uses Thereof
  • Ecdysone Receptor-Based Inducible Gene Expression System
  • Bioavailable Diacylhydrazine Ligands For Modulating The Expression Of Exogenous Genes Via An Ecdysone Receptor Complex
  • Fcγriib Specific Antibodies And Methods Of Use Thereof
  • Human Monoclonal Antibodies To Human Nucleolin
  • Identification Of Agents For Treating Calcium Disorders And Uses Thereof
  • Immunocytokine Sequences And Uses Thereof
  • Aβ Conformer Selective Anti-Aβ Globulomer Monoclonal Antibodies
  • Monoclonal Antibody Therapy For Pancreas Cancer
  • Interleukin-13 Binding Proteins
  • Amyloid-Beta Binding Proteins
  • Compositions For The Prevention And Treatment Of Smallpox
  • Hepatitis C Virus Codon Optimized Non-Structural Ns3/4a Fusion Gene
  • Bcr-Complex-Specific Antibodies And Methods Of Using Same
  • Expression Vectors Encoding Bispecific Fusion Proteins And Methods Of Producing Biologically Active Bispecific Fusion Proteins In A Mammalian Cell
  • Immunotheraphy Using Single Chain Polypeptide Binding Molecules
  • Human Kinase And Polynucleotides Encoding The Same
  • Psca: Prostate Stem Cell Antigen And Uses Thereof
  • Bcr-Abl1 Splice Variants And Uses Thereof
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Anti-Lgr5 Antibodies And Immunoconjugates
  • Antibodies To Apo-2 Receptor Polypeptides
  • Fcγriib Specific Antibodies And Methods Of Use Thereof
  • Human Kinases And Polynucleotides Encoding The Same
  • Human Carboxypeptidases And Polynucleotides Encoding The Same
  • Antibodies That Bind To Α2-Antiplasmin Crosslinked To Fibrin Which Do Not Inhibit Plasma Α2-Antiplasmin
  • Humanized Fcγriib-Specific Antibodies And Methods Of Use Thereof
  • Her-2 Binding Antagonists
  • Antibodies That Bind To The C35 Polypeptide
  • Thermostable Amylase Polypeptides, Nucleic Acids Encoding Those Polypeptides And Uses Thereof
  • Mn Gene And Protein
  • Trp8, A Transient Receptor Potential Channel Expressed In Taste Receptor Cells
  • Identification And Engineering Of Antibodies With Variant Fc Regions And Methods Of Using Same
  • T1r3 Transgenic Animals, Cells And Related Methods
  • Cytotoxic Antibodies Directed Against Antibodies Inhibiting Factor Viii
  • Whitefly Ecdysone Receptor Nucleic Acids, Polypeptides, And Uses Thereof
  • Tumor Necrosis Factor-Gamma
  • Methods For Producing Members Of Specific Binding Pairs
  • Transgenic Mammals Having Human Ig Loci Including Plural Vh And Vk Regions And Antibodies Produced Therefrom
  • Substitution Mutant Receptors And Their Use In An Ecdysone Receptor-Based Inducible Gene Expression System
  • Bi-Specific Monovalent Diabodies That Are Capable Of Binding To Gpa33 And Cd3, And Uses Thereof
  • Anti-Alpha V Beta 6 Antibodies And Uses Thereof
  • Soluble Mic Neutralizing Monoclonal Antibody For Treating Cancer
  • Stabilizing Agents And Capture Ligands For Use In Assays Measuring Analyte Concentrations
  • Compositions And Methods For The Therapy And Diagnosis Of Influenza
  • Ephb3-Specific Antibody And Uses Thereof
  • Glycosylated Specificity Exchangers
  • M-Csf-Specific Monoclonal Antibody And Uses Thereof
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Methods For Decreasing Immune Response And Treating Immune Conditions
  • Antibodies To Receptor Of Advanced Glycation End Products (Rage) And Uses Thereof
  • Treatment Of Vasculitis
  • Method Of Modulating Gene Expression Using An Ecdysone Receptor-Based Inducible Gene Expression System
  • Immunogen Platform
  • Mutant Igfbp-3 Molecules That Do Not Bind To Igfs, But Retain Their Ability To Functionally Bind Igfbp-3 Receptor
  • Methods For Producing Members Of Specific Binding Pairs
  • Apo-2 Receptor Polynucleotides
  • Hepatitis C Virus Codon Optimized Non-Structural Ns3/4a Fusion Gene
  • Methods And Compositions For The Treatment Of Proliferative And Pathogenic Diseases
  • Il-1 Binding Proteins
  • Markers For Breast Cancer
  • Bispecific Molecules That Are Immunoreactive With Immune Effector Cells Of A Companion Animal That Express An Activating Receptor And Cells That Express B7-H3 And Uses Thereof
  • Il-1 Binding Proteins
  • Hepatitis C Virus Codon Optimized Non-Structural Ns3/4a Fusion Gene
  • Diagnostic And Monitoring Methods For Cancer
  • Bacterial Xylanases
  • Production Of Chimeric Antibodies
  • Cloned Genes Encoding Ig-Cd4 Fusion Proteins And The Use Thereof
  • Method Of Identifying Bitter Compounds By Employing Trp8, A Transient Receptor Potential Channel Expressed In Taste Receptor Cells
  • Identification And Engineering Of Antibodies With Variant Fc Regions And Methods Of Using Same
  • Human Kinases And Polynucleotides Encoding The Same, And Uses Thereof
  • Hepatitis C Virus Non-Structural Ns3/4a Fusion Gene
  • Vaccines Containing Ribavirin And Methods Of Use Thereof
  • Purification Of Proteins With Cationic Surfactant
  • Antibodies Reactive With B7-H3 And Uses Thereof
  • Methods For Treating Progressive Multiple Sclerosis
  • Antibodies Reactive With B7-H3, Immunologically Active Fragments Thereof And Uses Thereof
  • Antibodies To Receptor Of Advanced Glycation End Products (Rage) And Uses Thereof
  • Psca: Prostate Stem Cell Antigen And Uses Thereof
  • Method Of Producing Bispecific Molecules By Protein Trans-Splicing
  • Soluble Analogues Of Integrins
  • Secreted Proteins
  • Antibodies Specific For Tgf-Beta And Methods For Treating Thereof
  • Covalent Diabodies And Uses Thereof
  • Her2/Neu-Specific Antibodies And Methods Of Using Same
  • Identification And Engineering Of Antibodies With Variant Fc Regions And Methods Of Using Same
  • Methods And Compositions For Modulating Hepsin Activation Of Macrophage-Stimulating Protein
  • Neukinase, A Downstream Protein Of Neuregulin
  • Ecdysone Receptor-Based Inducible Gene Expression System
  • Anti-Cancer Antibodies With Reduced Complement Fixation
  • Human Atpase Proteins And Polynucleotides Encoding The Same
  • Hepatitis C Virus Non-Structural Ns3/4a Fusion Gene
  • Methods Of Detecting Prostate Stem Cell Antigen In Cancer
  • Mammalian Suv39h2 Proteins And Isolated Dna Molecules Encoding Them
  • Human Kinase And Polynucleotides Encoding The Same
  • Human Protease Inhibitor And Polynucleotides Encoding The Same
  • Human Proteases And Polynucleotides Encoding The Same
  • Human Kinases And Polynucleotides Encoding The Same
  • Human Kinase Proteins And Polynucleotides Encoding The Same
  • Human Kinase Protein And Polynucleotides Encoding The Same
  • Human Proteins And Polynucleotides Encoding The Same
  • Methods For Treating Cancer Using Psca Antibodies And Fragments Thereof
  • Human Semaphorin Homologs And Polynucleotides Encoding The Same
  • Human Mitochondrial Proteins And Polynucleotides Encoding The Same
  • Method Of Prophylaxis Or Treatment Of Antigen Presenting Cell Driven Skin Conditions Using Inhibitors Of The Cd2/Lfa-3 Interaction
  • Human Proteases And Polynucleotides Encoding The Same
  • Human Kinases And Polynucleotides Encoding The Same
  • Human Kinases And Polynucleotides Encoding The Same
  • Human G-Coupled Protein Receptor Kinases And Polynucleotides Encoding The Same
  • Pyk2 Related Polypeptide Products
  • Mutant Br96 Antibodies Reactive With Human Carcinomas
  • Humanized Fcγriib-Specific Antibodies And Methods Of Use Thereof
  • Method For The Treatment Of Amyloidoses
  • Method For Preparing Targeted Carrier Erythrocytes
  • Molecular Recognition Units
  • Method For Making Humanized Antibodies
  • Human Kinases And Polynucleotides Encoding The Same
  • Stabilization Of Fc-Interferon-Beta Fusion Proteins
  • Amyloid-Beta Globulomer Antibodies
  • B. Anthracis Prevention And Treatment: Mutant B. Anthracis Lacking Luxs Activity And Furanone Inhibition Of Growth, Ai-2 Quorum Sensing, And Toxin Production
  • Il-1 Binding Proteins
  • Molecules With Antibody Combining Sites That Induce Asymmetry
  • Fc Region-Containing Polypeptides That Exhibit Improved Effector Function Due To Alterations Of The Extent Of Fucosylation, And Methods For Their Use
  • Psca: Prostate Stem Cell Antigen And Uses Thereof In Pancreatic Cancer
  • Compositions And Methods For The Therapy And Diagnosis Of Cytomegalovirus Infections
  • Methods And Compositions For Screening And Detecting Biomarkers
  • Aegyptin And Uses Thereof
  • Domain-Modified Constant Region Antibodies
  • Reducing The Immunogenicity Of Fusion Proteins
  • Antibodies That Bind To Α2-Antiplasmin Crosslinked To Fibrin Which Do Not Inhibit Plasma Α2-Antiplasmin
  • Compositions For The Prevention And Treatment Of Smallpox
  • Hepatitis C Virus Codon Optimized Non-Structural Ns3/4a Fusion Gene
  • Human Kinases And Polynucleotides Encoding The Same
  • Human Carboxypeptidases And Polynucleotides Encoding The Same
  • Anti-Lgr5 Antibodies And Immunoconjugates
  • Antibodies To Apo-2 Receptor Polypeptides
  • Expression Vectors Encoding Bispecific Fusion Proteins And Methods Of Producing Biologically Active Bispecific Fusion Proteins In A Mammalian Cell
  • Immunotheraphy Using Single Chain Polypeptide Binding Molecules
  • Bcr-Complex-Specific Antibodies And Methods Of Using Same
  • Human Kinase And Polynucleotides Encoding The Same
  • Psca: Prostate Stem Cell Antigen And Uses Thereof
  • Fcγriib Specific Antibodies And Methods Of Use Thereof
  • Markers For Breast Cancer
  • Soluble Mic Neutralizing Monoclonal Antibody For Treating Cancer
  • Il-1 Binding Proteins
  • Il-1 Binding Proteins
  • Methods And Compositions For The Treatment Of Proliferative And Pathogenic Diseases
  • Bispecific Molecules That Are Immunoreactive With Immune Effector Cells Of A Companion Animal That Express An Activating Receptor And Cells That Express B7-H3 And Uses Thereof
  • Compositions And Methods For The Therapy And Diagnosis Of Influenza
  • M-Csf-Specific Monoclonal Antibody And Uses Thereof
  • Glycosylated Specificity Exchangers
  • Antibodies Specific For Tgf-Beta And Methods For Treating Thereof
  • Psca: Prostate Stem Cell Antigen And Uses Thereof
  • Anti-Baff Antibodies
  • Compositions And Methods For The Therapy And Diagnosis Of Cytomegalovirus
  • Expression Vectors Encoding Bispecific Fusion Proteins And Methods Of Producing Biologically Active Bispecific Fusion Proteins In A Mammalian Cell
  • Her2/Neu-Specific Antibodies And Methods Of Using Same
  • Transgenic Animals For Producing Specific Isotypes Of Human Antibodies Via Non-Cognate Switch Regions
  • Hcv Antigen-Antibody Combination Assay And Methods And Compositions For Use Therein
  • Neukinase, A Downstream Protein Of Neuregulin
  • Combination Of Fcγriib-Specific Antibodies And Cd20-Specific Antibodies And Methods Of Use Thereof
  • Chimeric Antibodies With Receptor Binding Ligands In Place Of Their Constant Region.
  • Methods And Systems For Characterizing A Cellular Constituent Using Response Profiles
  • Diacylhydrazine Ligands For Modulating The Expression Of Exogenous Genes In Mammalian Systems Via An Ecdysone Receptor Complex
  • Mu Opioid Receptor Splice Variant Polypeptides, Polynucleotides And Methods Of Screening Compositions
  • Modulators Of Itch Ubiquitinase Activity
  • Antibodies That Bind To Repulsive Guidance Molecule A (Rgma)
  • Substitution Mutant Receptors And Their Use In A Nuclear Receptor-Based Inducible Gene Expression System
  • Hepatitis C Virus Codon Optimized Non-Structural Ns3/4a Fusion Gene
  • Thermostable Amylase Polypeptides, Nucleic Acids Encoding Those Polypeptides And Uses Thereof
  • Anti-Cancer Antibodies With Reduced Complement Fixation
  • Methods For Determining The Presence Of Carcinoma Using The Antigen Binding Region Of Monoclonal Antibody Br96
  • Production Of Antibodies Using Cre-Mediated Site-Specific Recombination
  • Chromosome 18 Marker
  • Nucleic Acid Encoding Ig-Cd4 Fusion Proteins
  • Pyk2 Related Polypeptide Products
  • Method For Molecular Diagnosis Of Tumor Angiogenesis And Metastasis
  • Methods And Compositions For The Diagnosis And Treatment Of Neuropsychiatric Disorders
  • Totally Synthetic Affinity Reagents
  • Bi-Specific Monovalent Diabodies That Are Capable Of Binding To Gpa33 And Cd3, And Uses Thereof
  • Anti-Alpha V Beta 6 Antibodies And Uses Thereof
  • Hybrid Proteins Between An Extracytoplasmic Enzyme And At Least Another Protein, Method For Preparing Them And Also Their Applications
  • Methods For Decreasing Immune Response And Treating Immune Conditions
  • Stabilizing Agents And Capture Ligands For Use In Assays Measuring Analyte Concentrations
  • Her-2 Binding Antagonists
  • Hepatitis C Virus Codon Optimized Non-Structural Ns3/4a Fusion Gene
  • Whitefly Ecdysone Receptor Nucleic Acids, Polypeptides, And Uses Thereof
  • Tumor Necrosis Factor-Gamma
  • Thermostable Amylase Polypeptides, Nucleic Acids Encoding Those Polypeptides And Uses Thereof
  • Methods For Producing Members Of Specific Binding Pairs
  • Antibodies That Bind To The C35 Polypeptide
  • Humanized Fcγriib-Specific Antibodies And Methods Of Use Thereof
  • Trp8, A Transient Receptor Potential Channel Expressed In Taste Receptor Cells
  • Identification And Engineering Of Antibodies With Variant Fc Regions And Methods Of Using Same
  • T1r3 Transgenic Animals, Cells And Related Methods
  • Transgenic Mammals Having Human Ig Loci Including Plural Vh And Vk Regions And Antibodies Produced Therefrom
  • Mutant Igfbp-3 Molecules That Do Not Bind To Igfs, But Retain Their Ability To Functionally Bind Igfbp-3 Receptor
  • Apo-2 Receptor Polynucleotides
  • Methods For Producing Members Of Specific Binding Pairs
  • Cytotoxic Antibodies Directed Against Antibodies Inhibiting Factor Viii
  • Mn Gene And Protein
  • Antibodies To Receptor Of Advanced Glycation End Products (Rage) And Uses Thereof
  • Treatment Of Vasculitis
  • Ephb3-Specific Antibody And Uses Thereof
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Immunogen Platform
  • Method Of Modulating Gene Expression Using An Ecdysone Receptor-Based Inducible Gene Expression System
  • Human Kinase And Polynucleotides Encoding The Same
  • Human Protease Inhibitor And Polynucleotides Encoding The Same
  • Mammalian Suv39h2 Proteins And Isolated Dna Molecules Encoding Them
  • Human Kinases And Polynucleotides Encoding The Same
  • Human Kinase Proteins And Polynucleotides Encoding The Same
  • Human Proteases And Polynucleotides Encoding The Same
  • Hepatitis C Virus Non-Structural Ns3/4a Fusion Gene
  • Methods Of Detecting Prostate Stem Cell Antigen In Cancer
  • Human G-Coupled Protein Receptor Kinases And Polynucleotides Encoding The Same
  • Hepatitis C Virus Non-Structural Ns3/4a Fusion Gene
  • Vaccines Containing Ribavirin And Methods Of Use Thereof
  • Human Semaphorin Homologs And Polynucleotides Encoding The Same
  • Method Of Prophylaxis Or Treatment Of Antigen Presenting Cell Driven Skin Conditions Using Inhibitors Of The Cd2/Lfa-3 Interaction
  • Human Proteases And Polynucleotides Encoding The Same
  • Human Semaphorin Homologs And Polynucleotides Encoding The Same
  • Vaccines Containing Ribavirin And Methods Of Use Thereof
  • Hepatitis C Virus Codon Optimized Non-Structural Ns3/4a Fusion Gene
  • Diagnostic And Monitoring Methods For Cancer
  • Human Mitochondrial Proteins And Polynucleotides Encoding The Same
  • Human Kinases And Polynucleotides Encoding The Same
  • Human Kinases And Polynucleotides Encoding The Same
  • Human Kinase Protein And Polynucleotides Encoding The Same
  • Human Proteins And Polynucleotides Encoding The Same
  • Methods For Treating Cancer Using Psca Antibodies And Fragments Thereof
  • Production Of Chimeric Antibodies
  • Cloned Genes Encoding Ig-Cd4 Fusion Proteins And The Use Thereof
  • Psca: Prostate Stem Cell Antigen And Uses Thereof
  • Method Of Producing Bispecific Molecules By Protein Trans-Splicing
  • Purification Of Proteins With Cationic Surfactant
  • Antibodies To Receptor Of Advanced Glycation End Products (Rage) And Uses Thereof
  • Antibodies Reactive With B7-H3, Immunologically Active Fragments Thereof And Uses Thereof
  • Methods For Treating Progressive Multiple Sclerosis
  • Covalent Diabodies And Uses Thereof
  • Substitution Mutant Receptors And Their Use In An Ecdysone Receptor-Based Inducible Gene Expression System
  • Mutant Br96 Antibodies Reactive With Human Carcinomas
  • Bifunctional Antibodies And Method Of Preparing Same
  • Granulocyte-Macrophage Colony-Stimulating Factor (Gm-Csf) Neutralizing Antibodies
  • Antibodies Reactive With B7-H3 And Uses Thereof
  • Soluble Analogues Of Integrins
  • Bacterial Xylanases
  • Human Atpase Proteins And Polynucleotides Encoding The Same
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Method Of Identifying Bitter Compounds By Employing Trp8, A Transient Receptor Potential Channel Expressed In Taste Receptor Cells
  • Identification And Engineering Of Antibodies With Variant Fc Regions And Methods Of Using Same
  • Human Kinases And Polynucleotides Encoding The Same, And Uses Thereof
  • Secreted Proteins
  • Il-17 Binding Proteins
  • Antibodies Against The Rgm A Protein And Uses Thereof
  • Ecdysone Receptor-Based Inducible Gene Expression System
  • Identification And Engineering Of Antibodies With Variant Fc Regions And Methods Of Using Same
  • Methods And Compositions For Modulating Hepsin Activation Of Macrophage-Stimulating Protein
  • Her2/Neu-Specific Antibodies And Methods Of Using Same
  • Therapeutic Dll4 Binding Proteins
  • Il-17 Binding Proteins
  • Deimmunized Serum-Binding Domains And Their Use In Extending Serum Half-Life
  • Compositions And Methods For The Therapy And Diagnosis Of Influenza
  • Vaccines Containing Ribavirin And Methods Of Use Thereof
  • Expression Of Functional Antibody Fragments
  • Fcγriib Specific Antibodies And Methods Of Use Thereof
  • Antibodies To Receptor For Advanced Glycation End Products (Rage) And Uses Thereof
  • Hybrid Immunoglobulin-Thrombolytic Enzyme Molecules Which Specifically Bind A Thrombus, And Methods Of Their Production And Use
  • Methods For Detection Of Nucleic Acid Polymorphisms Using Peptide-Labeled Oligonucleotides And Antibody Arrays
  • Methods For Treating Colon Cancer And Inflammation Associated With Overexpression Of Human Signal Peptide-Containing Proteins
  • Glycoprotein
  • Treatment With Anti-Alpha2 Integrin Antibodies
  • Fcγriib Specific Antibodies And Methods Of Use Thereof
  • Prlr-Specific Antibody And Uses Thereof
  • Identification And Engineering Of Antibodies With Variant Fc Regions And Methods Of Using Same
  • Methods Of Treating Retinal Nerve Fiber Layer Degeneration With Monoclonal Antibodies Against A Retinal Guidance Molecule (Rgm) Protein
  • Bioavailable Diacylhydrazine Ligands For Modulating The Expression Of Exogenous Genes Via An Ecdysone Receptor Complex
  • Polypeptide
  • Fusion Constructs And Use Of Same To Produce Antibodies With Increased Fc Receptor Binding Affinity And Effector Function
  • Antibodies To Plasminogen Activator Inhibitor-1 (Pai-1) And Uses Thereof
  • Substitution Mutant Receptors And Their Use In A Nuclear Receptor-Based Inducible Gene Expression System
  • Uncoupled Collagen Synthesis And Degradation Assays
  • Humanized Anti-Tgf-Beta Antibodies
  • Reducing The Immunogenicity Of Fusion Proteins
  • Antibodies Against Her3
  • Bcr-Abl1 Splice Variants And Uses Thereof
  • Methods For The Treatment Of Disease Using Immunoglobulins Having Fc Regions With Altered Affinities For Fcγractivating And Fcγrinhibiting
  • Bcr-Complex-Specific Antibodies And Methods Of Using Same
  • Recombinant Hybrid Immunoglobulin Molecules And Their Use
  • Fcγriib Specific Antibodies And Methods Of Use Thereof
  • Compositions And Methods For The Therapy And Diagnosis Of Cytomegalovirus
  • Isolation And Characterization Of The Csa Operon (Etec-Cs4 Pili) And Methods Of Using Same
  • Apaf-1 An Activator Of Caspase-3
  • Method For Enzymatic Production Of Decarboxylated Polyketides And Fatty Acids
  • Exo-Specific Amylase Polypeptides, Nucleic Acids Encoding Those Polypeptides And Uses Thereof
  • Proteins Comprising An Igg2 Domain
  • Enzymes
  • Human Endothelin Converting Enzyme-Like Proteins And Polynucleotides Encoding The Same
  • Expression Cloning Processes For The Discovery, Characterization And Isolation Of Genes Encoding Polypeptides With A Predetermined Property
  • Composition And Method For Enhancing Fibrinolysis
  • Highly Concentrated Aqueous Protein Solution With Reduced Viscosity
  • Substitution Mutant Receptors And Their Use In A Nuclear Receptor-Based Inducible Gene Expression System
  • Methods Of Making Antibody Heavy And Light Chains Having Specificity For A Desired Antigen
  • Combination Therapy With Co-Stimulatory Factors
  • Trp8, A Transient Receptor Potential Channel Expressed In Taste Receptor Cells
  • Il-7 Fusion Proteins
  • Gene Differentially Expressed In Breast And Bladder Cancer And Encoded Polypeptides
  • Ecdysone Receptor-Based Inducible Gene Expression System
  • Whitefly Ecdysone Receptor Antibody
  • Antibodies To Stra6 Polypeptides
  • Methods And Systems For Determining The Biological Function Of Cell Constituents Using Response Profiles
  • Methods Of Treating Viral Disorders
  • Mdki, A Novel Receptor Tyrosine Kinase
  • Mdk1 Polypeptides
  • Expression Vectors Encoding Bispecific Fusion Proteins And Methods Of Producing Biologically Active Bispecific Fusion Proteins In A Mammalian Cell
  • Totally Synthetic Affinity Reagents
  • Vectors With Pectate Lyase Signal Sequence
  • Human Phosphatases And Polynucleotides Encoding The Same
  • Apo-3 Polypeptide
  • Human Kinases And Polynucleotides Encoding The Same
  • Mu-Opiod Receptor Splice Variant Polypeptides
  • Human Gaba Receptor Proteins And Polynucleotides Encoding The Same
  • Non-Maltogenic Exoamylases And Their Use In Retarding Retrogradation Of Starch
  • Nucleic Acids Encoding Prostate Stem Cell Antigen
  • Human Protease Inhibitor And Polynucleotides Encoding The Same
  • Vaccines Containing Ribavirin And Methods Of Use Thereof
  • Psca: Prostate Stem Cell Antigen And Uses Thereof
  • Human Endothelin Converting Enzyme-Like Proteins And Polynucleotides Encoding The Same
  • Human Protocadherin Proteins And Polynucleotides Encoding The Same
  • Computer Systems And Computer Programs For Determining Protein Activity Levels Using Gene Expression Profiles
  • Polynucleotides Encoding Human Transporter Proteins
  • Human Proteases And Polynucleotides Encoding The Same
  • Human Proteases And Polynucleotides Encoding The Same
  • Human Kielin-Like Proteins And Polynucleotides Encoding The Same
  • Human Proteases And Polynucleotides Encoding The Same
  • Human Kinase Proteins And Polynucleotides Encoding The Same
  • Monoclonal Antibody To Novel Antigen Associated With Human Tumors
  • Composition And Method For Acceleration Of Clot Lysis
  • Engineering Fc Antibody Regions To Confer Effector Function
  • Glycosylated Specificity Exchangers
  • Thrombopoietic Compounds
  • Pdes And Uses Thereof
  • Boron-Containing Diacylhydrazines
  • Human Semaphorin Proteins And Polynucleotides Encoding The Same
  • Human Synaptotagmin And Polynucleotides Encoding The Same
  • Human Adenylsuccinate Synthetase And Polynucleotides Encoding The Same
  • Antibodies Specific For Tgf-Β And Methods Of Treatment Thereof
  • Methods For Treatment Or Diagnosis Of Diseases Or Disorders Associated With An Apb Domain
  • Anti-Semaphorin 3a Antibody And Treatment Of Alzheimer's Disease And Inflammatory Immune Diseases Using Same
  • Identification And Characterization Of Multiple Splice Variants Of The Kappa3-Related Opioid Receptor (Kor-3) Gene
  • Human Uncoupling Proteins And Polynucleotides Encoding The Same
  • Polynucleotides Encoding Human Gaba Receptors
  • Theramutein Modulators
  • Substitution Mutant Receptors And Their Use In An Ecdysone Receptor-Based Inducible Gene Expression System
  • Immunogen Platform
  • Antibodies Which Bind To Signal Peptide-Containing Molecules
  • Ecdysone Receptor-Based Inducible Gene Expression System
  • Il-17 Binding Proteins
  • Antibodies To Human Β-Adrenergic Receptor Kinase
  • Production Of A Single-Gene-Encoded Immunoglobulin
  • Modular Assembly Of Antibody Genes, Antibodies Prepared Thereby And Use
  • Non-Maltogenic Exoamylases And Their Use In Retarding Retrogradation Of Starch
  • Human Thymosin Protein And Polynucleotides Encoding The Same
  • Human Kinase Protein And Polynucleotides Encoding The Same
  • Antibodies To Human Tumor Necrosis Factor Receptor-Like 2
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Diacylhydrazine Ligands For Modulating The Expression Of Exogenous Genes In Mammalian Systems Via An Ecdysone Receptor Complex
  • Therapeutic Dll4 Binding Proteins
  • Leafhopper Ecdysone Receptor Nucleic Acids, Polypeptides, And Uses Thereof
  • Markers For Breast Cancer
  • Identification And Engineering Of Antibodies With Variant Fc Regions And Methods Of Using Same
  • Antibodies Reactive With B7-H3, Immunologically Active Fragments Thereof And Uses Thereof
  • Compounds And Method Of Identifying, Synthesizing, Optimizing And Profiling Protein Modulators
  • Methods For Detecting Expression Levels Of Human Signal Peptide-Containing Proteins (Hspp)
  • Bispecific Molecules That Are Immunoreactive With Immune Effector Cells That Express An Activating Receptor And An Antigen Expressed By A Cell Infected By A Virus And Uses Thereof
  • Secreted Proteins
  • Covalent Diabodies And Uses Thereof
  • Human Secreted Proteins And Polynucleotides Encoding The Same
  • Expression Vectors Encoding Bispecific Fusion Proteins And Methods Of Producing Biologically Active Bispecific Fusion Proteins In A Mammalian Cell
  • Human G-Coupled Protein Receptor Kinases And Polynucleotides Encoding The Same
  • Pectate Lyase Signal Sequence
  • Mutant Receptors And Their Use In A Nuclear Receptor-Based Inducible Gene Expression System
  • Modified Amylases, Nucleic Acids Encoding Those Amylases And Uses Thereof
  • Polynucleotides Encoding Antibodies That Bind To The C35 Polypeptide
  • Method For Treating Or Preventing Sclerotic Disorders Using Cd-2 Binding Agents
  • Selection Of Human Tnfα Specific Antibodies
  • Apo-2 Receptor Agonist Antibodies
  • Tumor Necrosis Factor-Gamma
  • Antibodies That Bind To The C35 Polypeptide
  • Immunocytokine Sequences And Uses Thereof
  • Methods For Producing Members Of Specific Binding Pairs
  • Method For Making Humanized Antibodies
  • Nucleic Acid Molecules Encoding Transmembrane Serine Proteases, The Encoded Proteins And Methods Based Thereon
  • Multiple Inducible Gene Regulation System
  • Methods Of Modulating Apoptosis By Administration Of Relaxin Agonists Or Antagonists
  • Modified Amylases From Pseudomonas Species, Methods Of Making And Uses Thereof
  • Stra6 Polypeptides
  • Identification And Engineering Of Antibodies With Variant Fc Regions And Methods Of Using Same
  • Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
  • Leafhopper Ecdysone Receptor Nucleic Acids, Polypeptides, And Uses Thereof
  • Hepatitis C Virus Non-Structural Ns3/4a Fusion Gene
  • Immunomodulation Of Inflammatory Conditions Utilizing Follistatin-Like Protein-1 And Agents That Bind Thereto
  • Aegyptin And Uses Thereof
  • Antibodies Reactive With B7-H3 And Uses Thereof
  • Secreted Proteins
  • Modulators Of Itch Ubiquitinase Activity
  • Binding Domains Of Proteins Of The Repulsive Guidance Molecule (Rgm) Protein Family And Functional Fragments Thereof, And Their Use
  • T Cell Receptors Specific For Immunodominant Ctl Epitopes Of Hcv
  • Abeta Conformer Selective Anti-Abeta Globulomer Monoclonal Antibodies
  • Il-1 Binding Proteins
  • Aβ Conformer Selective Anti-Aβ Globulomer Monoclonal Antibodies
  • Covalent Diabodies And Uses Thereof
  • Monoclonal Antibody To Novel Antigen Associated With Human Tumors
  • Boron-Containing Diacylhydrazine Compounds
  • Fcγriib Specific Antibodies And Methods Of Use Thereof
  • Treatment Of Pemphigus
  • Thrombopoietic Compounds
  • Il-I Binding Proteins
  • Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity
  • Il-1 Binding Proteins
  • Therameutin Modulators
  • Compositions Comprising Signal Peptide-Containing Proteins
  • Anti-Hemagglutinin Antibody Compositions And Methods Of Use Thereof
  • Antibodies Reactive With B7-H3 And Uses Thereof
  • Human Β-Adrenergic Receptor Kinase Polypeptide And Methods
  • Specific Antibodies Against Human Cxcl4 And Uses Thereof
  • Human Kinases And Polynucleotides Encoding The Same
  • Identification And Characterization Of Multiple Splice Variants Of The Mu-Opioid Receptor Gene
  • Monoclonal Antibody Br 96 And Chimeric Monoclonal Antibodies Having The Variable Region Of Mab Br96, Which Bind To A Variant Of Ley Antigen On Human Carcimona Cells
  • Therapeutic Dll4 Binding Proteins
  • Polypeptide
  • Hepatitis C Virus Codon Optimized Non-Structural Ns3/4a Fusion Gene
  • Transgenic Mammals Having Human Ig Loci Including Plural Vh And Vκ Regions And Antibodies Produced Therefrom
  • Method For The Diagnosis And Prognosis Of Malignant Diseases
  • Bioavailable Diacylhydrazine Ligands For Modulating The Expression Of Exogenous Genes Via An Ecdysone Receptor Complex
  • Fcγriib—Specific Antibodies And Methods Of Use Thereof
  • Method For Producing Recombinant Dna Proteins
  • Adhesion Variants
  • Totally Synthetic Affinity Reagents
  • Nucleic Acid Encoding Adhesion Variants
  • Human Kinases And Polynucleotides Encoding The Same
  • Specificity Exchangers That Redirect Antibodies To Bacterial Adhesion Receptors
  • Expression Vectors Encoding Bispecific Fusion Proteins And Methods Of Producing Biologically Active Bispecific Fusion Proteins In A Mammalian Cell
  • Production Of Antibodies Using Cre-Mediated Site-Specific Recombination
  • Hepatitis C Virus Codon Optimized Non-Structural Ns3/4a Fusion Gene
  • Modified Peptides As Therapeutic Agents
  • Glycosylated Specificity Exchangers
  • Whitefly Ecdysone Receptor Nucleic Acids, Polypeptides, And Uses Thereof
  • Human Transferase Proteins And Polynucleotides Encoding The Same
  • Chimeric Antibody With Specificity To Human B Cell Surface Antigen
  • Human Kinases And Polynucleotides Encoding The Same
  • Ligand/Receptor Specificity Exchangers That Redirect Antibodies To Receptors On A Pathogen
  • Apo-2li And Apo-3 Polypeptides
  • Cd3 Specific Recombinant Antibody
  • Human Kinase And Polynucleotides Encoding The Same
  • Human Carboxypeptidases And Polynucleotides Encoding The Same
  • Human Kinases And Polynucleotides Encoding The Same
  • Human Kinases And Polynucleotides Encoding The Same
  • In Vitro Scanning Saturation Mutagenesis Of Proteins
  • Method For Diagnosing Cancer Using Specific Psca Antibodies
  • Human Transporter Proteins And Polynucleotides Encoding The Same
  • Multivalent Antigen-Binding Proteins
  • Method For Preparing Soluble Analogues Of Integrins
  • Totally Synthetic Affinity Reagents
  • Host Cells And Method Of Producing Soluble Analogues Of Integrins
  • Screening Assays For Compounds
  • Chimeric Antibody With Specificity To Human B Cell Surface Antigen
  • Her2/Neu-Specific Antibodies And Methods Of Using The Same
  • Leafhopper Ecdysone Receptor Nucleic Acids, Polypeptides, And Uses Thereof
  • In Vivo Binding Pair Pretargeting
  • Recombinant Hybrid Immunoglobulin Molecules And Method Of Use
  • Antibodies Binding To Polypeptides Encoded By Developmentally-Regulated Endothelial Cell Locus-1
  • Human Uncoupling Proteins And Polynucleotides Encoding The Same
  • Recombinant N-Proteinase And Methods And Uses Thereof
  • Glycosylated Specificity Exchangers
  • Trp8, A Transient Receptor Potential Channel Expressed In Taste Receptor Cells
  • Methods For The Treatment Of Disease Using Immunoglobulins Having Fc Regions With Altered Affinities For Fcγractivating And Fcγrinhibiting
  • Thrombopoietic Compounds
  • Methods Of Modulating Apoptosis By Administration Of Relaxin Agonists Or Antagonists
  • Molecular Recognition Units
  • Whitefly Ecdysone Receptor Polypeptide And Methods
  • Thrombopoietic Compounds
  • Method For Predicting Responsiveness Of Breast Cancer To Antiestrogen Therapy
  • Methods For Producing Members Of Specific Binding Pairs
  • Treating A Mammal With A Formulation Comprising An Antibody Which Binds Ige
  • Process For Lowering The Viscosity Of Highly Concentrated Protein Solutions
  • Il-7 Fusion Proteins
  • Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells Activity
  • Non-Human Organism Comprising A Gene Expression Modulation System Encoding A Chimeric Retinoid X Receptor
  • Bioavailable Diacylhydrazine Ligands For Modulating The Expression Of Exogenous Genes Via An Ecdysone Receptor Complex
  • Covalently-Associated Diabody Complexes That Possess Charged Coil Domains And That Are Capable Of Enhanced Binding To Serum Albumin
  • Exo-Specific Amylase Polypeptides, Nucleic Acids Encoding Those Polypeptides And Uses Thereof
  • Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
  • Il-1 Binding Proteins
  • Theramutein Modulators
  • Therapeutic Dll4 Binding Proteins
  • Antibodies Reactive With B7-H3, Immunologically Active Fragments Thereof And Uses Thereof
  • Polynucleotides Encoding Signal Peptide-Containing Molecules
  • Glycosylated Ligand/Receptor Specificity Exchangers Specific For Bacterial Adhesion Receptors
  • Expression Of Functional Antibody Fragments
  • Human Proteases And Polynucleotides Encoding The Same
  • Production Of Antibodies Using Cre-Mediated Site-Specific Recombination
  • Non-Lethal Conditioning Methods For The Treatment Of Acquired Immunodeficiency Syndrome
  • Il-17 Binding Proteins
  • Antibody To Secreted Polypeptide
  • Human Hydroxylases And Polynucleotides Encoding The Same
  • Methods For Producing Members Of Specific Binding Pairs
  • Anti-Nucleolin Agent-Conjugated Nanoparticles
  • Anti-Cancer Antibodies With Reduced Complement Fixation
  • Il-17 Binding Proteins
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/312604a0

    DOI

    http://dx.doi.org/10.1038/312604a0

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1047097780

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/6095112


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Immunology", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antibodies, Monoclonal", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antigen-Antibody Complex", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Line", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Chimera", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cloning, Molecular", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "DNA Restriction Enzymes", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Disulfides", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Genes", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Haptens", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hybridomas", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunoglobulin Fab Fragments", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Lymphocytes", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Micrococcal Nuclease", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Oncogenes", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Plasmacytoma", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Plasmids", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Staphylococcus aureus", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Transfection", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "familyName": "Neuberger", 
            "givenName": "Michael S.", 
            "id": "sg:person.01043211662.37", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01043211662.37"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "Williams", 
            "givenName": "Gareth T.", 
            "id": "sg:person.01144540002.35", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144540002.35"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "Fox", 
            "givenName": "Robert O.", 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/296410a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000250420", 
              "https://doi.org/10.1038/296410a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/256495a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001387921", 
              "https://doi.org/10.1038/256495a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/eji.1830091216", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012260265"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/309364a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019506442", 
              "https://doi.org/10.1038/309364a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s1874-6047(08)60368-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024806608"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/309810a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035092927", 
              "https://doi.org/10.1038/309810a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.80.3.825", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036904999"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.80.20.6351", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043356466"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/305240a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043374191", 
              "https://doi.org/10.1038/305240a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.78.4.2072", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051147601"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/j.1460-2075.1983.tb01594.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1074660083"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/j.1460-2075.1983.tb01749.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1081678065"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1082112763", 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1984-12", 
        "datePublishedReg": "1984-12-01", 
        "description": "The introduction into lymphocytes of immunoglobulin-gene DNA that has been manipulated in vitro allows the production of novel antibodies. In this way, cell lines have been established that secrete hapten-specific antibodies in which the Fc portion has been replaced either with an active enzyme moiety or with polypeptide displaying c-myc antigenic determinants.", 
        "genre": "research_article", 
        "id": "sg:pub.10.1038/312604a0", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1018957", 
            "issn": [
              "0090-0028", 
              "1476-4687"
            ], 
            "name": "Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "5995", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "312"
          }
        ], 
        "name": "Recombinant antibodies possessing novel effector functions", 
        "pagination": "604", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "e05bc62b278e4982549812129bb7e677cc62f1838812f98c1422414eb6da4dcf"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "6095112"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "0410462"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/312604a0"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1047097780"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/312604a0", 
          "https://app.dimensions.ai/details/publication/pub.1047097780"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-10T16:29", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8669_00000426.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://www.nature.com/articles/312604a0"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/312604a0'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/312604a0'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/312604a0'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/312604a0'


     

    This table displays all metadata directly associated to this object as RDF triples.

    199 TRIPLES      21 PREDICATES      62 URIs      41 LITERALS      29 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/312604a0 schema:about N1aa5a60638dd4a8a8421dcf724878397
    2 N1da47095382f4b678a94995b09a056e8
    3 N3a7d85bc96b9482f992da6ab23950590
    4 N494c764722064fa4abac9153e48a760b
    5 N4d5b13e6451c409fb8902a9388c5b75d
    6 N4f455ceec19444f8969c8b8d1bdb2fb1
    7 N65aca5124b974d97acf4b320bfb2fa48
    8 N6c728a6e923c4d52a9323d9d93ada703
    9 N6cd120bb41504a0b9e1e6b3b8e7958ec
    10 N6fd6892914b64bb59a365ab33aa71e3c
    11 N7a01da2a271949f999bfc017518ff43f
    12 N7fa3256bb57c42a081c601f3b062ff55
    13 N83446225c14449cf968b6f3f787fd5c4
    14 Naecbac088a544509bd5e17e36d00ae06
    15 Nbde3d3c224674f6487fe2aef13634b6b
    16 Nc81919fe6631464d80a094f65013a455
    17 Nce0925c6cfb5495fab5f813e60e8fa12
    18 Nd0026ca6f93c461fb4fa01bd586d8be0
    19 Ndae0d1ccce4444ca958fe5433ef838b8
    20 Ne080093bb372478ba16b893de686b73e
    21 anzsrc-for:11
    22 anzsrc-for:1107
    23 schema:author N76e9071895ef45758159152fb3af4d15
    24 schema:citation sg:pub.10.1038/256495a0
    25 sg:pub.10.1038/296410a0
    26 sg:pub.10.1038/305240a0
    27 sg:pub.10.1038/309364a0
    28 sg:pub.10.1038/309810a0
    29 https://app.dimensions.ai/details/publication/pub.1082112763
    30 https://doi.org/10.1002/eji.1830091216
    31 https://doi.org/10.1002/j.1460-2075.1983.tb01594.x
    32 https://doi.org/10.1002/j.1460-2075.1983.tb01749.x
    33 https://doi.org/10.1016/s1874-6047(08)60368-6
    34 https://doi.org/10.1073/pnas.78.4.2072
    35 https://doi.org/10.1073/pnas.80.20.6351
    36 https://doi.org/10.1073/pnas.80.3.825
    37 schema:datePublished 1984-12
    38 schema:datePublishedReg 1984-12-01
    39 schema:description The introduction into lymphocytes of immunoglobulin-gene DNA that has been manipulated in vitro allows the production of novel antibodies. In this way, cell lines have been established that secrete hapten-specific antibodies in which the Fc portion has been replaced either with an active enzyme moiety or with polypeptide displaying c-myc antigenic determinants.
    40 schema:genre research_article
    41 schema:inLanguage en
    42 schema:isAccessibleForFree false
    43 schema:isPartOf N234d021e37f8497fb65a157efd736d7b
    44 Ndaa8aaa737a5448a8dcf1000f211b541
    45 sg:journal.1018957
    46 schema:name Recombinant antibodies possessing novel effector functions
    47 schema:pagination 604
    48 schema:productId N779ae122bb5547c39289f653ee70c416
    49 N8db992dec7c549d2917f7576007b1cef
    50 N9c77426b34984e078ebaa4ec7fa98ee8
    51 Nc18a362a584d492c8c4aa254d7cfc3c8
    52 Nef60a9ad247949878462b8c805fc5e73
    53 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047097780
    54 https://doi.org/10.1038/312604a0
    55 schema:sdDatePublished 2019-04-10T16:29
    56 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    57 schema:sdPublisher N413cf95859794cd0bbb5f8f4f0345140
    58 schema:url https://www.nature.com/articles/312604a0
    59 sgo:license sg:explorer/license/
    60 sgo:sdDataset articles
    61 rdf:type schema:ScholarlyArticle
    62 N125a77b9c1554b729af2bb31c44f0983 rdf:first sg:person.01144540002.35
    63 rdf:rest Nfd7298ae65654083afe646ae0780f4b0
    64 N1aa5a60638dd4a8a8421dcf724878397 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    65 schema:name Antibodies, Monoclonal
    66 rdf:type schema:DefinedTerm
    67 N1da47095382f4b678a94995b09a056e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    68 schema:name Antigen-Antibody Complex
    69 rdf:type schema:DefinedTerm
    70 N234d021e37f8497fb65a157efd736d7b schema:volumeNumber 312
    71 rdf:type schema:PublicationVolume
    72 N3a7d85bc96b9482f992da6ab23950590 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    73 schema:name Cell Line
    74 rdf:type schema:DefinedTerm
    75 N413cf95859794cd0bbb5f8f4f0345140 schema:name Springer Nature - SN SciGraph project
    76 rdf:type schema:Organization
    77 N494c764722064fa4abac9153e48a760b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    78 schema:name Hybridomas
    79 rdf:type schema:DefinedTerm
    80 N4d5b13e6451c409fb8902a9388c5b75d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    81 schema:name Micrococcal Nuclease
    82 rdf:type schema:DefinedTerm
    83 N4f455ceec19444f8969c8b8d1bdb2fb1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    84 schema:name DNA Restriction Enzymes
    85 rdf:type schema:DefinedTerm
    86 N65aca5124b974d97acf4b320bfb2fa48 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    87 schema:name Plasmacytoma
    88 rdf:type schema:DefinedTerm
    89 N6c728a6e923c4d52a9323d9d93ada703 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    90 schema:name Animals
    91 rdf:type schema:DefinedTerm
    92 N6cd120bb41504a0b9e1e6b3b8e7958ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    93 schema:name Disulfides
    94 rdf:type schema:DefinedTerm
    95 N6fd6892914b64bb59a365ab33aa71e3c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    96 schema:name Chimera
    97 rdf:type schema:DefinedTerm
    98 N76e9071895ef45758159152fb3af4d15 rdf:first sg:person.01043211662.37
    99 rdf:rest N125a77b9c1554b729af2bb31c44f0983
    100 N779ae122bb5547c39289f653ee70c416 schema:name doi
    101 schema:value 10.1038/312604a0
    102 rdf:type schema:PropertyValue
    103 N7a01da2a271949f999bfc017518ff43f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    104 schema:name Haptens
    105 rdf:type schema:DefinedTerm
    106 N7fa3256bb57c42a081c601f3b062ff55 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    107 schema:name Genes
    108 rdf:type schema:DefinedTerm
    109 N83446225c14449cf968b6f3f787fd5c4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    110 schema:name Immunoglobulin Fab Fragments
    111 rdf:type schema:DefinedTerm
    112 N8c09312ea8354da0a7735dbec5449679 schema:familyName Fox
    113 schema:givenName Robert O.
    114 rdf:type schema:Person
    115 N8db992dec7c549d2917f7576007b1cef schema:name pubmed_id
    116 schema:value 6095112
    117 rdf:type schema:PropertyValue
    118 N9c77426b34984e078ebaa4ec7fa98ee8 schema:name dimensions_id
    119 schema:value pub.1047097780
    120 rdf:type schema:PropertyValue
    121 Naecbac088a544509bd5e17e36d00ae06 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    122 schema:name Plasmids
    123 rdf:type schema:DefinedTerm
    124 Nbde3d3c224674f6487fe2aef13634b6b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    125 schema:name Staphylococcus aureus
    126 rdf:type schema:DefinedTerm
    127 Nc18a362a584d492c8c4aa254d7cfc3c8 schema:name readcube_id
    128 schema:value e05bc62b278e4982549812129bb7e677cc62f1838812f98c1422414eb6da4dcf
    129 rdf:type schema:PropertyValue
    130 Nc81919fe6631464d80a094f65013a455 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    131 schema:name Mice
    132 rdf:type schema:DefinedTerm
    133 Nce0925c6cfb5495fab5f813e60e8fa12 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    134 schema:name Oncogenes
    135 rdf:type schema:DefinedTerm
    136 Nd0026ca6f93c461fb4fa01bd586d8be0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    137 schema:name Cloning, Molecular
    138 rdf:type schema:DefinedTerm
    139 Ndaa8aaa737a5448a8dcf1000f211b541 schema:issueNumber 5995
    140 rdf:type schema:PublicationIssue
    141 Ndae0d1ccce4444ca958fe5433ef838b8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    142 schema:name Lymphocytes
    143 rdf:type schema:DefinedTerm
    144 Ne080093bb372478ba16b893de686b73e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    145 schema:name Transfection
    146 rdf:type schema:DefinedTerm
    147 Nef60a9ad247949878462b8c805fc5e73 schema:name nlm_unique_id
    148 schema:value 0410462
    149 rdf:type schema:PropertyValue
    150 Nfd7298ae65654083afe646ae0780f4b0 rdf:first N8c09312ea8354da0a7735dbec5449679
    151 rdf:rest rdf:nil
    152 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    153 schema:name Medical and Health Sciences
    154 rdf:type schema:DefinedTerm
    155 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
    156 schema:name Immunology
    157 rdf:type schema:DefinedTerm
    158 sg:journal.1018957 schema:issn 0090-0028
    159 1476-4687
    160 schema:name Nature
    161 rdf:type schema:Periodical
    162 sg:person.01043211662.37 schema:familyName Neuberger
    163 schema:givenName Michael S.
    164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01043211662.37
    165 rdf:type schema:Person
    166 sg:person.01144540002.35 schema:familyName Williams
    167 schema:givenName Gareth T.
    168 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144540002.35
    169 rdf:type schema:Person
    170 sg:pub.10.1038/256495a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001387921
    171 https://doi.org/10.1038/256495a0
    172 rdf:type schema:CreativeWork
    173 sg:pub.10.1038/296410a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000250420
    174 https://doi.org/10.1038/296410a0
    175 rdf:type schema:CreativeWork
    176 sg:pub.10.1038/305240a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043374191
    177 https://doi.org/10.1038/305240a0
    178 rdf:type schema:CreativeWork
    179 sg:pub.10.1038/309364a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019506442
    180 https://doi.org/10.1038/309364a0
    181 rdf:type schema:CreativeWork
    182 sg:pub.10.1038/309810a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035092927
    183 https://doi.org/10.1038/309810a0
    184 rdf:type schema:CreativeWork
    185 https://app.dimensions.ai/details/publication/pub.1082112763 schema:CreativeWork
    186 https://doi.org/10.1002/eji.1830091216 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012260265
    187 rdf:type schema:CreativeWork
    188 https://doi.org/10.1002/j.1460-2075.1983.tb01594.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1074660083
    189 rdf:type schema:CreativeWork
    190 https://doi.org/10.1002/j.1460-2075.1983.tb01749.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1081678065
    191 rdf:type schema:CreativeWork
    192 https://doi.org/10.1016/s1874-6047(08)60368-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024806608
    193 rdf:type schema:CreativeWork
    194 https://doi.org/10.1073/pnas.78.4.2072 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051147601
    195 rdf:type schema:CreativeWork
    196 https://doi.org/10.1073/pnas.80.20.6351 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043356466
    197 rdf:type schema:CreativeWork
    198 https://doi.org/10.1073/pnas.80.3.825 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036904999
    199 rdf:type schema:CreativeWork
     




    Preview window. Press ESC to close (or click here)


    ...